Login to Your Account

Mabspace moving to clinic with Lilly-backed $15M series A round

By Cornelia Zou
Staff Writer

Monday, November 2, 2015

HONG KONG – Start-up antibody-focused Mabspace Biosciences Co. Ltd. has secured $15 million in series A financing with Lilly Asia Ventures to help move two of its cancer candidates into clinical studies and further its antibody pipeline.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription